Invokana Warnings Update Required by FDA

The FDA has finally announced that stronger warnings will be required for a popular new generation of diabetes drugs, known as SGLT2 inhibitors, providing further support for Invokana lawsuits, Farxiga lawsuits and other failure to warn claims being investigated by the lawyers at Saiontz & Kirk,… Read More

Austin Kirk

By
December 8, 2015 | No Comments

Zofran MDL for Birth Defect Lawsuits Established

With a growing number of Zofran birth defect lawsuits continuing to be filed by families throughout the U.S., each raising similar allegations that GlaxoSmithKline failed to adequately warn about the risks associated with using the medication during pregnancy, the litigation has been consolidated in the federal… Read More

Austin Kirk

By
October 14, 2015 | No Comments